The products will vary from patient friendly platforms with easy to control facilities to more sophisticated versions for the medical practitioner. We are cooperating with UK and European based electronic companies as well as an accessories manufacturer with an established background in the pain management market.
Remedius Neuromodulation Technologies
MISSION STATEMENT
HISTORICAL PERSPECTIVE
Remedius Ltd is a company dedicated to innovative neuromodulation technologies ranging from very simple to very sophisticated applications for pain control and improved function. Peripheral neuromodulation, where our main focus lies, has been known about since ancient times and the first recorded written report was published by Scribonius Largus, a Roman physician, who described the use of an electric eel to effectively treat patients with gout and headache. The history of the use of electricity in medicine is full of discoveries and successes but also setbacks. Please see a brief history of the use of electricity in medicine below.
HISTORY OF MEDICAL ELECTRICITY FOR PAIN
Modern use of neuromodulation in medicine is firmly related to the postulated pain gate theory by Melzack and Wall in 1965. The same year they used the first peripheral neuromodulation application followed by the first implantation of dorsal column stimulation which is now called spinal cord stimulation. The first peripheral implant was carried out in 1967 followed by the very continuous growth in popularity, indications and of course effectiveness of this treatment. Peripheral neurostimulation was carried out exclusively for surgical implantations until 1999 when the first percutaneous insertion of peripheral leads took place by Weiner and Reid. Since the beginning of this century there has been an enormous expansion of the various indications and techniques of neuromodulation and specifically its peripheral branch
Cutaneous stimulation is not new. It has been practised with various modifications in the 18th, 19th and 20th centuries however modern applications of cutaneous stimulation started with the introduction of transcutaneous electrical nerve stimulation. This method is very popular but only moderately effective for various types of pain.
RECENT DISCOVERIES AND DEVELOPMENTS
The introduction of a low frequency nerve locating device in the treatment of mainly neuropathic pain by Dr Teodor Goroszeniuk at St Thomas’ Hospital, London in 2002 created new exciting possibilities. Initially devices not built for neuromodulation treatments were used with quite good results in various applications but mainly in the treatment of neuropathic pain. Applications of low frequency electrical fields in the treatment of neuropathic pain is gaining popularity and is currently in use in multiple centres in the UK, Europe and further afield. The Remedius team are dedicated to the design and production of external neuromodulation devices and multiple accessories related to the treatment of pain and improvement of function. The designs range from special physician led multifunctional units to smaller devices permitting patients to use them at home for self-administration. Accessories to those devices are very attractive and can range from single to multi electrode leads for treatment of various painful conditions in single nerve distribution or plexus distributions or even so-called target field applications including facial pains, occipital neuralgia or headache.
HISTORY OF MEDICAL ELECTRICITY FOR PAIN
Modern use of neuromodulation in medicine is firmly related to the postulated pain gate theory by Melzack and Wall in 1965. The same year they used the first peripheral neuromodulation application followed by the first implantation of dorsal column stimulation which is now called spinal cord stimulation. The first peripheral implant was carried out in 1967 followed by the very continuous growth in popularity, indications and of course effectiveness of this treatment. Peripheral neurostimulation was carried out exclusively for surgical implantations until 1999 when the first percutaneous insertion of peripheral leads took place by Weiner and Reid. Since the beginning of this century there has been an enormous expansion of the various indications and techniques of neuromodulation and specifically its peripheral branch
Cutaneous stimulation is not new. It has been practised with various modifications in the 18th, 19th and 20th centuries however modern applications of cutaneous stimulation started with the introduction of transcutaneous electrical nerve stimulation. This method is very popular but only moderately effective for various types of pain.
RECENT DISCOVERIES AND DEVELOPMENTS
The introduction of a low frequency nerve locating device in the treatment of mainly neuropathic pain by Dr Teodor Goroszeniuk at St Thomas’ Hospital, London in 2002 created new exciting possibilities. Initially devices not built for neuromodulation treatments were used with quite good results in various applications but mainly in the treatment of neuropathic pain. Applications of low frequency electrical fields in the treatment of neuropathic pain is gaining popularity and is currently in use in multiple centres in the UK, Europe and further afield. The Remedius team are dedicated to the design and production of external neuromodulation devices and multiple accessories related to the treatment of pain and improvement of function. The designs range from special physician led multifunctional units to smaller devices permitting patients to use them at home for self-administration. Accessories to those devices are very attractive and can range from single to multi electrode leads for treatment of various painful conditions in single nerve distribution or plexus distributions or even so-called target field applications including facial pains, occipital neuralgia or headache.
Subscribe to:
Posts (Atom)